Legofer

Iron Protein Succinylate, the active ingredient in Legofer, is an iron supplement presented as an oral formulation for oral use. It is employed to treat iron deficiency anemia and other iron deficiency states in patients requiring increased iron intake. GNH USA supplies Legofer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Legofer is an oral iron supplement used to address conditions related to insufficient iron levels.

Iron deficiency anemia: helps restore normal hemoglobin concentrations and improve red blood cell production. Iron deficiency: supports replenishment of depleted iron stores in the body. Chronic blood loss: assists in correcting iron loss associated with ongoing gastrointestinal or menstrual bleeding.

Legofer may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Constipation: reduced bowel movements. - Abdominal discomfort: cramping or pain. - Darkened stools: harmless change in stool color. - Metallic taste: transient alteration in taste perception. - Diarrhea: occasional loose stools.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Anaphylaxis: rapid onset of life‑threatening symptoms. - Iron overload: excessive iron accumulation with prolonged high dosing. - Severe abdominal pain: persistent or worsening pain. - Hypotension: unusually low blood pressure.

Before initiating therapy with Legofer, consider the following precautions.

Assess iron status: confirm deficiency through laboratory testing. Monitor therapy: regularly check hemoglobin and ferritin levels. Avoid hypersensitivity: discontinue if allergic reactions occur. Use cautiously in gastrointestinal disease: patients with IBD may experience increased irritation. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Legofer can interact with several medications, affecting absorption or efficacy.

Major Interactions (Avoid): - Tetracycline antibiotics: chelation reduces absorption of both agents. - Levothyroxine: iron may impair thyroid hormone uptake. - Bisphosphonates: concurrent use diminishes absorption of each.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: may decrease iron absorption. - Proton pump inhibitors: reduce gastric acidity, limiting iron uptake. - Calcium supplements: compete for intestinal transport mechanisms. - Vitamin C: can increase iron absorption, potentially leading to excess.